高级检索
当前位置: 首页 > 详情页

Heat Shock Transcription Factor 2 Promotes Mitophagy of Intestinal Epithelial Cells Through PARL/PINK1/Parkin Pathway in Ulcerative Colitis

| 导出 | |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Kunming Medical University, Kunming, China, [2]Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, China, [3]Yunnan Province Clinical Research Center for Digestive Diseases, Kunming, China, [4]Department of Ultrasound, First Affiliated Hospital of Kunming Medical University, Kunming, China, [5]Organ Transplantation Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China
出处:
ISSN:

关键词: heat shock transcription factor 2 mitophagy intestinal epithelial cells ulcerative colitis pathogenesis

摘要:
The overactivation of NLRP3 inflammasome in intestinal epithelial cells (IECs) is among the important reasons for severe inflammation in ulcerative colitis (UC). We found that heat shock transcription factor 2 (HSF2), which is highly expressed in UC, could inhibit the activation of NLRP3 inflammasome and reduce IL-1 beta in IECs, but the mechanisms were still not clear. It has been reported that HSP72 regulated by HSF2 can enhance the mitophagy mediated by Parkin. The number of damaged mitochondria and the mitochondrial derived ROS (mtROS) can be reduced by mitophagy, which means the activity of NLRP3 inflammasome is inhibited. Therefore, we speculate that HSF2 might regulate the activation of NLRP3 inflammasome of IECs in UC through the mitophagy mediated by Parkin. This study proves that the number of damaged mitochondria in IECs, the level of mitophagy, and the level of ROS in intestinal mucosa are positively correlated with the severity of UC. In mice and cells, mitophagy was promoted by HSF2 through the PARL/PINK1/Parkin pathway. This study reveals the potential mechanisms of HSF2 decreasing mtROS of IECs in UC.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 2 区 药学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 药学
JCR分区:
出版当年[2022]版:
Q1 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Kunming Medical University, Kunming, China, [2]Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, China, [3]Yunnan Province Clinical Research Center for Digestive Diseases, Kunming, China,
共同第一作者:
通讯作者:
通讯机构: [2]Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, China, [3]Yunnan Province Clinical Research Center for Digestive Diseases, Kunming, China,
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:56919 今日访问量:0 总访问量:1772 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)